期刊文献+

Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats 被引量:5

Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats
下载PDF
导出
摘要 AIM: To observe the alterations in gut microbiota in high-fat diet(HFD)-induced diabetes recurrence after duodenal-jejunal bypass(DJB) in rats. METHODS: We assigned HDF- and low-dose streptozotocin-induced diabetic rats into two major groups to receive DJB and sham operation respectively. When the DJB was completed, we used HFD to induce diabetes recurrence. Then, we grouped the DJB-operated rats by blood glucose level into the DJB-remission(DJB-RM) group and the DJB-recurrence(DJB-RC) group. At a sequence of time points after operations, we compared calorie content in the food intake(calorie intake), oral glucose tolerance test, homeostasis model assessment of insulin resistance(HOMA-IR), concentrations of glucagon-like peptide 1(GLP-1), serum insulin, total bile acids(TBAs) and lipopolysaccharide(LPS) and alterations in colonic microbiota.RESULTS: The relative abundance of Firmicutes in the control(58.06% ± 11.12%; P < 0.05 vs sham; P < 0.05 vs DJB-RC) and DJB-RM(55.58% ± 6.16%; P < 0.05 vs sham; P < 0.05 vs DJB-RC) groups was higher than that in the sham(29.04% ± 1.36%) and DJB-RC(27.44% ± 2.17%) groups; but the relative abundance of Bacteroidetes was lower(control group: 33.46% ± 10.52%, P < 0.05 vs sham 46.88% ± 2.34%, P < 0.05 vs DJB-RC 47.41% ± 5.67%. DJB-RM group: 34.63% ± 3.37%, P < 0.05 vs sham; P < 0.05 vs DJB-RC). Escherichia coli was higher in the sham(15.72% ± 1.67%, P < 0.05 vs control, P < 0.05 vs DJB-RM) and DJB-RC(16.42% ± 3.00%; P < 0.05 vs control; P < 0.05 vs DJB-RM) groups than in the control(3.58% ± 3.67%) and DJB-RM(4.15% ± 2.76%) groups. Improved HOMA-IR(2.82 ± 0.73, P < 0.05 vs DJB-RC 4.23 ± 0.72), increased TBAs(27803.17 ± 4673.42 ng/m L; P < 0.05 vs DJB-RC 18744.00 ± 3047.26 ng/m L) and decreased LPS(0.12 ± 0.04 ng/m L, P < 0.05 vs DJBRC 0.19 ± 0.03 ng/m L) were observed the in DJB-RM group; however, these improvements were reversed in the DJB-RC group, with the exception of GLP-1(DJB-RM vs DJB-RC P > 0.05). CONCLUSION: Alterations in gut microbiota may be responsible for the diabetes remission and recurrence after DJB, possibly by influencing serum LPS and TBAs. AIM: To observe the alterations in gut microbiota in high-fat diet (HFD)-induced diabetes recurrence after duodenal-jejunal bypass (DJB) in rats. METHODS: We assigned HDF- and low-dose streptozotocin-induced diabetic rats into two major groups to receive DJB and sham operation respectively. When the DJB was completed, we used HFD to induce diabetes recurrence. Then, we grouped the DJB-operated rats by blood glucose level into the DJB-remission (DJB-RM) group and the DJB-recurrence (DJB-RC) group. At a sequence of time points after operations, we compared calorie content in the food intake (calorie intake), oral glucose tolerance test, homeostasis model assessment of insulin resistance (HOMA-IR), concentrations of glucagon-like peptide 1 (GLP-1), serum insulin, total bile acids (TBAs) and lipopolysaccharide (LPS) and alterations in colonic microbiota. RESULTS: The relative abundance of Firmicutes in the control (58.06% +/- 11.12%; P < 0.05 vs sham; P < 0.05 vs DJB-RC) and DJB-RM (55.58% +/- 6.16%; P < 0.05 vs sham; P < 0.05 vs DJB-RC) groups was higher than that in the sham (29.04% +/- 1.36%) and DJB-RC (27.44% +/- 2.17%) groups; but the relative abundance of Bacteroidetes was lower (control group: 33.46% +/- 10.52%, P < 0.05 vs sham 46.88% +/- 2.34%, P < 0.05 vs DJB-RC 47.41% +/- 5.67%. DJB-RM group: 34.63% +/- 3.37%, P < 0.05 vs sham; P < 0.05 vs DJB-RC). Escherichia coli was higher in the sham (15.72% +/- 1.67%, P < 0.05 vs control, P < 0.05 vs DJB-RM) and DJB-RC(16.42% +/- 3.00%; P < 0.05 vs control; P < 0.05 vs DJB-RM) groups than in the control (3.58% +/- 3.67%) and DJB-RM (4.15% +/- 2.76%) groups. Improved HOMA-IR (2.82 +/- 0.73, P < 0.05 vs DJB-RC 4.23 +/- 0.72), increased TBAs (27803.17 +/- 4673.42 ng/mL; P < 0.05 vs DJB-RC 18744.00 +/- 3047.26 ng/mL) and decreased LPS (0.12 +/- 0.04 ng/mL, P < 0.05 vs DJBRC 0.19 +/- 0.03 ng/mL) were observed the in DJB-RM group; however, these improvements were reversed in the DJB-RC group, with the exception of GLP-1 (DJB-RM vs DJB-RC P > 0.05). CONCLUSION: Alterations in gut microbiota may be responsible for the diabetes remission and recurrence after DJB, possibly by influencing serum LPS and TBAs.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第29期6706-6715,共10页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China,(No.81471019 to Hu SY No.81300286 to Liu SZ No.81370496 to Zhang GY) the Taishan Scholar Foundation(to Hu SY)
关键词 Duodenal-jejunal bypass Gut microbiota DIABETES RECURRENCE Lipopolysaccharide Total BILE acids Duodenal-jejunal bypass Gut microbiota Diabetes recurrence Lipopolysaccharide Total bile acids
  • 相关文献

参考文献45

  • 1Brethauer SA,Aminian A,Romero-Talamas H,Batayyah E,Mackey J,Kennedy L,Kashyap SR,Kirwan JP,Rogula T,Kroh M et al.Can diabetes be surgically cured?Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Annals of Surgery . 2013
  • 2Drucker Daniel J.The role of gut hormones in glucose homeostasis. The Journal of Clinical Investigation . 2007
  • 3Larsen Nadja,Vogensen Finn K,van den Berg Frans W J,Nielsen Dennis Sandris,Andreasen Anne Sofie,Pedersen Bente K,Al-Soud Waleed Abu,S?rensen S?ren J,Hansen Lars H,Jakobsen Mogens.Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS one . 2010
  • 4Chenhong Zhang,Menghui Zhang,Shengyue Wang.Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME JOURNAL . 2010
  • 5Peter J. Turnbaugh,Ruth E. Ley,Micah Hamady,Claire M. Fraser-Liggett,Rob Knight,Jeffrey I. Gordon.The Human Microbiome Project. Nature . 2007
  • 6David Heber,Frank L. Greenway,Lee M. Kaplan,Edward Livingston,Javier Salvador,Christopher Still.??Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline(J)The Journal of Clinical Endocrinology & Metabolism . 2010 (11)
  • 7Effects of the gut microbiota on obesity and glucose homeostasis(J)Trends in Endocrinology & Metabolism . 2011 (4)
  • 8Breen, Danna M,Yue, Jessica T Y,Rasmussen, Brittany A,Kokorovic, Andrea,Cheung, Grace W C,Lam, Tony K T.??Duodenal PKC-[delta] and Cholecystokinin Signaling Axis Regulates Glucose Production(J)Diabetes . 2011 (12)
  • 9S. R. Kashyap,P. Schauer.??Clinical considerations for the management of residual diabetes following bariatric surgery(J)Diabetes, Obesity and Metabolism . 2012 (9)
  • 10N. A.Rhee,T.Vilsb?ll,F. K.Knop.??Current evidence for a role of GLP‐1 in Roux‐en‐Y gastric bypass‐induced remission of type 2 diabetes(J)Diabetes, Obesity and Metabolism . 2012 (4)

二级参考文献36

  • 1Wild S,Roglic G,Green A,Sicree R,King H.Global prevalence of diabetes:estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053.
  • 2Hossain P,Kawar B,El Nahas M.Obesity and diabetes in the developing world-a growing challenge.N Engl J Med 2007;356:213-215.
  • 3Kopelman PG.Obesity as a medical problem.Nature 2000;404:635-643.
  • 4Mokdad AH,Ford ES,Bowman BA,Dietz WH,Vinicor F,Bales VS,et al.Prevalence of obesity,diabetes,and obesity-related health risk factors,2001. JAMA 2003; 289:76-79.
  • 5Gastrointestinal surgery for severe obesity:National Institutes of Health Consensus Development Conference Statement.Am J Clin Nutr 1992; 55:615S-619S.
  • 6Pories WJ,Swanson MS,MacDonald KG,Long SB,Morris PG,Brown BM,et al.Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.Ann Surg 1995; 222:339-350.
  • 7Buchwald H,Estok R,Fahrbach K,Banel D,Jensen MD,Pories WJ,et al.Weight and type 2 diabetes after bariatric surgery:systematic review and meta-analysis.Am J Med 2009; 122:248-256. e5.
  • 8Schauer PR,Burguera B,Ikramuddin S,Cottam D,Gourash W,Hamad G,et al.Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.Ann Surg 2003; 238:467-484; discussion 484-465.
  • 9Torquati A,Lutfi R,Abumrad N,Richards WO.Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 2005; 9:1112-1116; discussion 1117-1118.
  • 10Dixon JB,O'Brien PE,Playfair J,Chapman L,Schachter LM,Skinner S,et al.Adjustable gastric banding and conventional therapy for type 2 diabetes:a randomized controlled trial.JAMA 2008; 299:316-323.

共引文献28

同被引文献23

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部